Table 2.
Key clinical features of women with ovarian malignant tumors, ovarian benign tumors and healthy women (controls)
| Characteristics |
Malignant |
Benign |
Controls |
p-value |
p-value |
p-value |
|---|---|---|---|---|---|---|
| (n = 60) | (n = 116) | (n = 150) | (Malignant vs. benign) | (Malignant vs. controls) | (Benign vs. controls) | |
|
Age | ||||||
| Years, mean (SD)* |
50.8 (20.5) |
47.9 (16.6) |
44.4 (12.6) |
0.45 |
0.02 |
0.18 |
|
Menopausal statusŦ | ||||||
| Premenopausal |
23 (38.3) |
68 (57.8) |
79 (52.6) |
|
|
|
| Postmenopausal |
38 (61.7) |
49 (42.2) |
71 (48.4) |
<0.01 |
0.05 |
0.37 |
|
Body mass index (BMI) – kg/m2 | ||||||
| Mean (+/− SD)* |
28.3 (+/−6.3) |
28.0 (+/−5.5) |
27.2 (+/−5.0) |
0.42 |
0.37 |
0.40 |
|
Histology | ||||||
| Epithelial |
47 (78.3) |
40 (34.5) |
- |
- |
- |
- |
|
Invasive |
37 (78.7) |
|
|
|
|
|
|
Borderline |
10 (21.3) |
|
|
|
|
|
| Germ line |
6 (10.0) |
28 (24.1) |
- |
- |
- |
- |
| Sex cord and Stromal |
7 (12.7) |
20 (17.3) |
- |
- |
- |
- |
| Non-neoplasic |
- |
28 (24.1) |
- |
- |
- |
- |
|
Stage | ||||||
| I |
32 (53.3) |
|
|
|
|
|
| II |
5 (8.3) |
|
|
|
|
|
| III |
22 (36.7) |
|
|
|
|
|
| IV | 1 (1.7) | |||||
p values calculated with either chi-squaresŦ or the Kruskal-Wallis test*.
*2 ovarian carcinomas had endometrial carcinoma associated; for these cases ovarian carcinoma was considered the primary tumor.